Amlodipine preserves the glomerular number in spontaneously hypertensive rats

Area of Science:

• Nephrology
• Cardiovascular Pharmacology

Background:

• Calcium channel blockers are established antihypertensive agents, particularly in patients with renal disease.
• Their renal effects may extend beyond blood pressure reduction.
• Hypertension-induced kidney damage, including glomerulosclerosis, is a significant clinical concern.

Purpose of the Study:

• To investigate the renoprotective effects of amlodipine in spontaneously hypertensive rats (SHR).
• To assess the impact of amlodipine on blood pressure, serum creatinine, proteinuria, and glomerular number in SHR.
• To determine if amlodipine offers benefits beyond its antihypertensive action in a model of chronic kidney disease.

Main Methods:

• Fifteen male SHR were divided into three groups: initial control (IC), final control (FC) receiving standard chow, and amlodipine (Aml) receiving 0.2 mg/kg/day for 15 weeks.
• Blood pressure (BP) was monitored throughout the study.
• Serum creatinine and proteinuria were measured.
• Glomerular number was estimated using the disector method.

Main Results:

• Amlodipine treatment significantly reduced BP in SHR by approximately 50% compared to baseline.
• Serum creatinine levels were significantly lower in the amlodipine group compared to the final control group.
• The final control group exhibited a significant reduction in glomerular number compared to both initial control and amlodipine groups, suggesting a protective effect of amlodipine against glomeruli loss.

Conclusions:

• Amlodipine demonstrates significant antihypertensive efficacy in SHR.
• Beyond BP reduction, amlodipine may exert a protective effect against glomeruli loss in hypertensive rats.
• These findings suggest amlodipine could be a valuable therapeutic option for hypertensive patients with existing renal lesions, offering additional renoprotective benefits.